Bausch Health Companies Inc.
BHC.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 209.41% | -950.00% | 115.63% | -64.10% | 89.68% |
| Total Depreciation and Amortization | -4.66% | 1.26% | -0.63% | -2.74% | 9.30% |
| Total Amortization of Deferred Charges | 2.94% | -37.04% | 285.71% | -62.16% | 32.14% |
| Total Other Non-Cash Items | 3,425.00% | 123.53% | -41.67% | -110.30% | -51.36% |
| Change in Net Operating Assets | -192.06% | 293.75% | 191.43% | 79.41% | -14.86% |
| Cash from Operations | 48.40% | 6.58% | 80.09% | -45.90% | 38.30% |
| Capital Expenditure | -49.30% | 8.97% | 4.88% | 16.33% | -133.33% |
| Sale of Property, Plant, and Equipment | -100.00% | 400.00% | 0.00% | -- | -100.00% |
| Cash Acquisitions | -102.22% | -- | -- | -- | 99.84% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -133.33% | 550.00% | -125.00% | 117.02% | -1,040.00% |
| Cash from Investing | -96.08% | -29.11% | -8.22% | 50.68% | 92.17% |
| Total Debt Issued | -- | -100.00% | 6.67% | -48.63% | -94.57% |
| Total Debt Repaid | -150.61% | 66.87% | -26.92% | -92.12% | 75.15% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 40.00% | -25.00% | 71.43% | -1,300.00% | 87.50% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 65.00% | -300.00% | 54.55% | 47.62% | 57.14% |
| Cash from Financing | 144.97% | 55.42% | -24.71% | -330.38% | -104.35% |
| Foreign Exchange rate Adjustments | -369.23% | 244.44% | -80.00% | -126.32% | 211.76% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 255.12% | 196.21% | 36.23% | -213.74% | -5.21% |
